Substance Use Disorders: Withdrawal Syndromes — Alcohol (DTs), Opioids, Benzodiazepines

Substance Use Disorders: Withdrawal Syndromes — Alcohol (DTs), Opioids, Benzodiazepines

A high-density, practical guide for clinicians, nurses, and first responders.

What Is This?

Withdrawal syndromes are acute, life-threatening physiological and psychological reactions that occur when a person abruptly stops or reduces chronic substance use. This guide focuses on alcohol (Delirium Tremens), opioids, and benzodiazepines—three of the most dangerous withdrawal scenarios in clinical practice.

Why it matters today: - 1 in 8 ER visits in the U.S. involves substance use disorders (SUDs). - Alcohol withdrawal kills ~5% of untreated patients (DTs mortality rate). - Opioid withdrawal, while rarely fatal, drives relapse and overdose risk. - Benzodiazepine withdrawal can cause seizures, psychosis, and prolonged disability.

Why It Matters

Real-World Impact

1. Patient Safety: Untreated withdrawal can progress to seizures, cardiac arrest, or suicide.
2. Clinical Efficiency: Early recognition and protocol-driven management reduce ICU admissions by 50%.
3. Public Health: Withdrawal is a critical intervention point to engage patients in long-term SUD treatment.
4. Legal & Ethical: Failure to treat withdrawal may constitute medical negligence (e.g., EMTALA violations in U.S. hospitals).

Core Concepts

1. Neuroadaptation & Dependence

• Chronic substance use rewires the brain’s reward and stress pathways.
• Alcohol/GABA: Enhances inhibitory GABA receptors-sudden cessation causes hyperexcitability (seizures, DTs).
• Opioids/mu-receptors: Suppresses noradrenaline-withdrawal triggers sympathetic overdrive (tachycardia, hypertension).
• Benzodiazepines/GABA-A: Downregulates receptors-abrupt stop causes rebound anxiety, seizures.

2. Withdrawal Timeline & Severity

3. Key Clinical Tools

• CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol): 10-item scale to guide benzodiazepine dosing.
• COWS (Clinical Opiate Withdrawal Scale): 11-item scale for opioid withdrawal severity.
• Fixed vs. Symptom-Triggered Dosing:
• Fixed: Scheduled benzodiazepines (e.g., chlordiazepoxide 50mg q6h).
• Symptom-triggered: Dose only when CIWA-Ar-8 (reduces total benzodiazepine use by 30%).

4. The "Kindling Effect"

• Repeated withdrawals lower the seizure threshold-each subsequent withdrawal is more severe.
• Why it matters: A patient with 3+ prior withdrawals is high-risk for DTs even with mild symptoms.

5. Protracted Withdrawal (PAWS)

• Post-Acute Withdrawal Syndrome (PAWS): Persistent symptoms (anxiety, insomnia, cravings) for months to years.
• Alcohol: Depression, sleep disturbances.
• Opioids: Anhedonia, fatigue.
• Benzodiazepines: Cognitive impairment ("brain fog").

How It Works: Pathophysiology & Management

Alcohol Withdrawal (Delirium Tremens - DTs)

1. Mechanism:
2. Chronic alcohol enhances GABA (inhibitory) and inhibits glutamate (excitatory).

3. Sudden cessation-glutamate surge-hyperexcitability (seizures, hallucinations, autonomic instability).

4. Stages:

5. Stage 1 (6–24 hrs): Tremors, anxiety, nausea.
6. Stage 2 (24–48 hrs): Hallucinations (visual > auditory), hypertension.

7. Stage 3 (48–72 hrs): DTs (confusion, fever, tachycardia, seizures).

8. Management:

9. Benzodiazepines (1st line): Lorazepam (2–4mg IV/IM q15–30min) or diazepam (10mg IV q5–10min).
10. Adjuncts:
    • Thiamine (100mg IV/IM daily) to prevent Wernicke-Korsakoff.
    • Magnesium (2g IV) if deficient (low Mg lowers seizure threshold).
    • Beta-blockers (e.g., propranolol) for tachycardia (but do not mask DTs).

Opioid Withdrawal

1. Mechanism:

2. Chronic opioids suppress noradrenaline-abrupt cessation-noradrenergic storm (diarrhea, piloerection, hypertension).

3. Symptoms (COWS Score):

4. Mild (5–12): Yawning, lacrimation, rhinorrhea.
5. Moderate (13–24): Pupil dilation, gooseflesh, myalgia.

6. Severe (25–48): Vomiting, diarrhea, hypertension, tachycardia.

7. Management:

8. Opioid Agonist Therapy (OAT):
   • Methadone (20–30mg PO, titrate up) or buprenorphine (4–8mg SL, max 32mg/day).
9. Adjuncts:
   • Clonidine (0.1–0.2mg PO q4–6h) for autonomic symptoms.
   • Loperamide (4mg PO, then 2mg after each loose stool) for diarrhea.
   • NSAIDs (ibuprofen 400mg q6h) for myalgia.

Benzodiazepine Withdrawal

1. Mechanism:

2. Chronic benzos downregulate GABA-A receptors-abrupt stop-rebound hyperexcitability (seizures, psychosis).

3. Symptoms:

4. Early (1–4 days): Anxiety, insomnia, tremors.

5. Late (1–2 weeks): Hallucinations, seizures, catatonia (rare but deadly).

6. Management:

7. Slow taper (10% dose reduction every 1–2 weeks).
8. Switch to long-acting benzo (e.g., diazepam) for smoother taper.
9. Adjuncts:
   • Carbamazepine (200–400mg PO BID) for seizure prophylaxis.
   • Propranolol (20mg PO TID) for autonomic symptoms.

Hands-On: Step-by-Step Management

Prerequisites

• Knowledge: Basic pharmacology (GABA, glutamate, noradrenaline).
• Tools:
• CIWA-Ar/COWS scales.
• IV access, cardiac monitor, pulse oximeter.
• Benzodiazepines (lorazepam/diazepam), thiamine, magnesium.

Alcohol Withdrawal (DTs) Protocol

1. Assess severity (CIWA-Ar):
2. Score < 8: Supportive care (fluids, thiamine, electrolytes).
3. Score 8–15: Lorazepam 2mg IV/IM q1h PRN.

4. Score > 15 or DTs: Lorazepam 4mg IV q15min until sedated (max 20mg/hr).

5. Monitor:

6. Vitals q15min (BP, HR, temp).

7. Seizure precautions (padded bed rails, suction ready).

8. Adjuncts:

9. Thiamine 100mg IV (before glucose to prevent Wernicke’s).
10. Magnesium 2g IV if deficient.

Opioid Withdrawal Protocol

1. Assess severity (COWS):
2. Score < 12: Supportive care (clonidine, loperamide, NSAIDs).

3. Score-12: Buprenorphine 4mg SL (if in moderate withdrawal; wait 1–2 hrs to avoid precipitated withdrawal).

4. Monitor:

5. Vitals q2h (BP, HR).

6. Hydration status (diarrhea-hypovolemia).

7. Adjuncts:

8. Clonidine 0.1mg PO q4h (max 0.8mg/day).
9. Loperamide 4mg PO, then 2mg after each loose stool.

Benzodiazepine Withdrawal Protocol

1. Convert to diazepam (long-acting):

2. Example: Patient on alprazolam 2mg TID-switch to diazepam 20mg TID.

3. Taper schedule:

4. Week 1–2: Reduce by 10% every 3–5 days.

5. Week 3+: Reduce by 5% every 1–2 weeks.

6. Monitor for seizures:

7. Carbamazepine 200mg PO BID if high-risk.

Common Pitfalls & Mistakes

1. Underestimating alcohol withdrawal:
2. Mistake: Assuming "mild tremors" won’t progress to DTs.

3. Fix: CIWA-Ar every 1–2 hrs for first 24 hrs.

4. Precipitated opioid withdrawal:

5. Mistake: Giving buprenorphine too early (before COWS-12).

6. Fix: Wait until objective signs (pupil dilation, gooseflesh).

7. Rapid benzo taper:

8. Mistake: Reducing dose by >10% per week.

9. Fix: Slow taper (5–10% every 1–2 weeks) to avoid seizures.

10. Ignoring thiamine in alcohol withdrawal:

11. Mistake: Giving glucose before thiamine-risk of Wernicke’s.

12. Fix: Thiamine 100mg IV first, then glucose.

13. Overlooking PAWS:

14. Mistake: Discharging a patient after acute withdrawal without follow-up for PAWS.
15. Fix: Refer to SUD treatment programs (e.g., MAT for opioids).

Best Practices

1. Use symptom-triggered dosing (CIWA-Ar/COWS) over fixed schedules-reduces benzodiazepine overuse.
2. Always check electrolytes (Mg, K, PO4) in alcohol withdrawal-low Mg increases seizure risk.
3. Avoid antipsychotics (e.g., haloperidol) in alcohol withdrawal-lowers seizure threshold.
4. For opioid withdrawal, buprenorphine > methadone in outpatient settings (lower abuse potential).
5. Document CIWA-Ar/COWS scores every 1–2 hrs-critical for legal defense if complications arise.

Tools & Frameworks

Real-World Use Cases

1. Emergency Department (Alcohol Withdrawal)

• Scenario: A 45M with 10-year heavy alcohol use presents with tremors, tachycardia (HR 120), BP 180/100.
• Action:
• CIWA-Ar = 18-lorazepam 4mg IV q15min until sedated.
• Thiamine 100mg IV, magnesium 2g IV.
• Admit to ICU if DTs develop (fever, hallucinations).

2. Outpatient Clinic (Opioid Withdrawal)

• Scenario: A 30F with heroin use disorder wants to quit but fears withdrawal.
• Action:
• COWS = 15-buprenorphine 4mg SL (wait 1 hr, then 4mg more if needed).
• Clonidine 0.1mg PO q4h for autonomic symptoms.
• Refer to MAT program for long-term buprenorphine.

3. Inpatient Psychiatry (Benzodiazepine Withdrawal)

• Scenario: A 50M on alprazolam 2mg TID for 5 years wants to taper.
• Action:
• Switch to diazepam 20mg TID (longer half-life).
• Taper by 10% every 2 weeks.
• Carbamazepine 200mg BID for seizure prophylaxis.

Check Your Understanding (MCQs)

Question 1

A 55M with 20-year alcohol use presents with tremors, BP 160/90, HR 110. CIWA-Ar score is 12. What is the most appropriate next step?

A) Discharge with oral diazepam 10mg TID. B) Administer lorazepam 2mg IV and reassess in 1 hour. C) Start haloperidol 5mg IM for agitation. D) Give thiamine 100mg PO and observe.

Correct Answer: B - Why: CIWA-Ar 8–15 requires benzodiazepines (lorazepam 2mg IV). Reassess in 1 hr. - Distractors: - A: Oral diazepam is too slow for moderate withdrawal. - C: Haloperidol lowers seizure threshold (contraindicated in alcohol withdrawal). - D: Thiamine is not urgent in this scenario (give IV, not PO).

Question 2

A 28F with oxycodone use disorder presents with yawning, lacrimation, and dilated pupils. COWS score is 14. She requests buprenorphine. What is the best next step?

A) Administer buprenorphine 8mg SL immediately. B) Give clonidine 0.1mg PO and reassess in 2 hours. C) Wait 1 hour, then give buprenorphine 4mg SL. D) Start methadone 30mg PO daily.

Correct Answer: C - Why: Buprenorphine can precipitate withdrawal if given too early. Wait 1 hr to confirm COWS-12. - Distractors: - A: Risk of precipitated withdrawal (buprenorphine has higher affinity for mu-receptors). - B: Clonidine is not first-line for moderate withdrawal (buprenorphine is more effective). - D: Methadone is not first-line in acute withdrawal (better for maintenance).

Question 3

A 60